rac-4-(4-Chlorophenyl)-N-(3,5-dichlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-carboxamide

ID: ALA4590976

PubChem CID: 155568207

Max Phase: Preclinical

Molecular Formula: C20H15Cl3N2OS

Molecular Weight: 437.78

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(Nc1cc(Cl)cc(Cl)c1)N1CCc2sccc2C1c1ccc(Cl)cc1

Standard InChI:  InChI=1S/C20H15Cl3N2OS/c21-13-3-1-12(2-4-13)19-17-6-8-27-18(17)5-7-25(19)20(26)24-16-10-14(22)9-15(23)11-16/h1-4,6,8-11,19H,5,7H2,(H,24,26)

Standard InChI Key:  KWWIBEXHEKAHKD-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
   35.1919  -26.6258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9047  -26.2171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9047  -25.3913    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   35.1919  -24.9741    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1923  -24.1492    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9091  -23.7369    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9095  -22.9119    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1939  -22.4982    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4763  -22.9155    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4794  -23.7392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4792  -26.2171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.4792  -25.3866    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6895  -25.1300    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.2013  -25.8018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6895  -26.4736    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   36.6210  -24.9804    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.3350  -25.3954    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   36.6235  -24.1547    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.0514  -24.9846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.7620  -25.4032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4778  -24.9931    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   39.4808  -24.1664    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.7618  -23.7516    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0488  -24.1641    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   40.1916  -25.4085    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   38.7613  -22.9258    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   35.1928  -21.6724    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
 12  4  1  0
 11  1  1  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10  5  1  0
  4  5  1  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 11  1  0
  3 16  1  0
 16 17  1  0
 16 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 21 25  1  0
 23 26  1  0
  8 27  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4590976

    ---

Associated Targets(Human)

LHCGR Tclin Luteinizing hormone/Choriogonadotropin receptor (373 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 437.78Molecular Weight (Monoisotopic): 435.9971AlogP: 6.89#Rotatable Bonds: 2
Polar Surface Area: 32.34Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 1HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.74CX Basic pKa: CX LogP: 6.60CX LogD: 6.60
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.46Np Likeness Score: -1.92

References

1. Wortmann L, Lindenthal B, Muhn P, Walter A, Nubbemeyer R, Heldmann D, Sobek L, Morandi F, Schrey AK, Moosmayer D, Günther J, Kuhnke J, Koppitz M, Lücking U, Röhn U, Schäfer M, Nowak-Reppel K, Kühne R, Weinmann H, Langer G..  (2019)  Discovery of BAY-298 and BAY-899: Tetrahydro-1,6-naphthyridine-Based, Potent, and Selective Antagonists of the Luteinizing Hormone Receptor Which Reduce Sex Hormone Levels in Vivo.,  62  (22): [PMID:31670515] [10.1021/acs.jmedchem.9b01382]

Source